Sponsor Deadline
Posted: 3/19/2025

Innovation Grants to Nurture Initial Translational Efforts (IGNITE): Assay Development and Neurotherapeutic Agent Identification (R61/R33 Clinical Trial Not Allowed)

This Notice of Funding Opportunity (NOFO) encourages research grant applications to develop in vitro, ex vivo or in vivo assays and conduct iterative screening efforts to identify and characterize potential therapeutic agents for neurological or neuromuscular disorders.This NOFO is part of a suite of Innovation Grants to Nurture Initial Translational Efforts (IGNITE).

 

Companion FOAs:

PAR-25-058 , R61/ R33 Phase 1 Exploratory/Developmental Grant/ Exploratory/Developmental Grants Phase II
PAR-25-060 , R61/ R33 Phase 1 Exploratory/Developmental Grant/ Exploratory/Developmental Grants Phase II

Deadlines:

  • Application Due Dates: Feb 18, 2025; June 18, 2025; Oct 20, 2025; Feb 18, 2026; June 18, 2026; Oct 20, 2026; Feb 18, 2027; June 18, 2027; Oct 20, 2027

PAR-25-059 Expiration Date October 21, 2027

Amount Description

Direct Costs cannot exceed $499,000 in any one year and cumulative direct costs for the three year project cannot exceed $750,000.

Amount
$750,000
Funding Type
Eligibility
Posted
3/19/2025
Deadline
Sponsor: